The drugs listed below had modifications to the BOXED WARNING, CONTRAINDICATIONS, and/or MEDICATION GUIDES published during June, 2008: 

*OPTISON (Perflutren Protein -Type A Microspheres Injectable Suspension, USP) *VIRAMUNE (nevirapine) Tablets and Oral Suspension *APTIVUS (tipranavir) Capsules and Oral Solution *ATRIPLA (efavirenz/emtricitabine/tenofovir disoproxil fumarate) Tablets *AVODART (dutasteride) Soft Gelatin Capsules *CONCERTA (methylphenidate HCl) Extended-Release Tablets *KALETRA (lopinavir and ritonavir) Tablet, Film Coated for Oral Use *KALETRA (lopinavir and ritonavir) Solution for Oral Use *RECLAST (zoledronic acid) Injection *ZYVOX (linezolid) Injection, Zyvox (linezolid) Tablets, and Zyvox (linezolid) for Oral Suspension *FORTEO (teriparatide [rDNA origin]) Injection *PegINTRON/REBETOL Combo Pack containing:  PegIntron REDIPEN Single-dose Delivery System (peginterferon alfa-2b) and REBETOL (ribavirin, USP) Capsules 

These changes can be viewed at: http://www.fda.gov/medwatch/SAFETY/2008/jun08.htm


Zynchros Pharmacy Services